Home > Insider Trading > Filing (0001140361-17-021154)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1561387	Health Insurance Innovations Inc.	HIIQ	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1366007	Bruce Telkamp	C/O Health Insurance Innovations, Inc. 15438 N. Florida Ave., Suite 201 Tampa FL 33613	Ceo Of Healthpocket, Inc.*	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Class A Common Stock	Acquisiton	2017-05-15	2,988	$6.77	104,489	No	4	M	Direct
Class A Common Stock	Disposition	2017-05-15	895	$22.60	103,594	No	4	D	Direct
Class A Common Stock	Disposition	2017-05-15	2,093	$22.60	101,501	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	D	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Class A Common Stock	Stock Appreciation Rights	Disposition	2017-05-15	2,988	$0.00	2,988	$6.77

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
17,012		2021-05-25	No	4	M	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Class A Common Stock	Stock Appreciation Rights	$12.13		2021-07-14	6,000	6,000	Direct
Class A Common Stock	Stock Appreciation Rights	$4.95		2022-07-01	30,000	30,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2021-07-14	6,000	6,000	Direct
2022-07-01	30,000	30,000	Direct

Footnotes

Shares retained by the issuer to satisfy the exercise price of stock appreciation rights exercised by the reporting person.
These stock-settled stock appreciation rights were granted under the Issuer's Long-Term Incentive Plan (the "Plan") and became vested as follows: (i) 42,000 on the first date on which the average trading price of the Company's Class A common stock was at or above $12.00 per share for the preceding 30 consecutive trading days, and (ii) 42,000 on the first date on which the average trading price of the Company's Class A common stock was at or above $16.00 per share for the preceding 30 consecutive trading days, all subject to the terms of the Plan and an award agreement under the Plan.
These stock-settled stock appreciation rights were previously granted under the Plan and are scheduled to vest in increments of 20%, 20%, 20%, and 40% on successive anniversary dates of the grant, subject to the terms of the Plan and an award agreement under the Plan.
These stock-settled stock appreciation rights were previously granted under the Plan and are scheduled to vest in increments of 25%, 25%, and 50% on successive anniversary dates of the grant, subject to the terms of the Plan and an award agreement under the Plan.